Literature DB >> 14607271

Mechanisms and effectors of MIF-dependent promotion of tumourigenesis.

Robert A Mitchell1.   

Abstract

The importance of secreted cytokines and growth factors in the development and promotion of malignancies is often underestimated. Many different soluble, extracellular gene products participate in processes that collectively contribute to the growth and survival of a developing neoplasm. These secreted molecules can, directly or indirectly, play a central role in uncontrolled tumour cell division, angiogenic stimulation or suppression of tumour cell immune surveillance. One of the first cytokine activities ever described, macrophage migration inhibitory factor (MIF), is unique to these soluble mediators in that it participates in all of these pro-tumourigenic processes. Overexpressed in most tumour types examined, MIF has been shown to promote malignant cell transformation, inhibit tumour cell-specific immune cytolytic responses and strongly enhance neovascularization. Despite this broad array of activities, the elucidation of molecular and cellular mechanisms involved in MIF-dependent bioactions has remained elusive. This review will focus on recently characterized phenotypes and mechanistic effectors thought to be associated with MIF-dependent promotion of neoplastic processes and discuss their relative importance in carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14607271     DOI: 10.1016/j.cellsig.2003.07.002

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  44 in total

Review 1.  Disturbances in placental immunology: ready for therapeutic interventions?

Authors:  Sinuhe Hahn; Anurag Kumar Gupta; Carolyn Troeger; Corinne Rusterholz; Wolfgang Holzgreve
Journal:  Springer Semin Immunopathol       Date:  2006-04-26

2.  MIF and autophagy: a novel link beyond "eating".

Authors:  Omar El Bounkari; Jürrgen Bernhagen
Journal:  Cell Res       Date:  2012-05-08       Impact factor: 25.617

3.  Proteomic analysis of osteogenic sarcoma: association of tumour necrosis factor with poor prognosis.

Authors:  Justin M M Cates; David B Friedman; Erin H Seeley; William D Dupont; Herbert S Schwartz; Ginger E Holt; Richard M Caprioli; Pampee P Young
Journal:  Int J Exp Pathol       Date:  2010-03-26       Impact factor: 1.925

Review 4.  Macrophage migration inhibitory factor manipulation and evaluation in tumoral hypoxic adaptation.

Authors:  Millicent Winner; Lin Leng; Wayne Zundel; Robert A Mitchell
Journal:  Methods Enzymol       Date:  2007       Impact factor: 1.600

Review 5.  Cancer-related inflammation.

Authors:  Juliana Candido; Thorsten Hagemann
Journal:  J Clin Immunol       Date:  2012-12-09       Impact factor: 8.317

6.  Expression of macrophage migration inhibitory factor relates to survival in high-grade osteosarcoma.

Authors:  Ilkyu Han; Mi Ra Lee; Kwang Woo Nam; Joo Han Oh; Kyung Chul Moon; Han-Soo Kim
Journal:  Clin Orthop Relat Res       Date:  2008-06-18       Impact factor: 4.176

7.  A tautomerase-null macrophage migration-inhibitory factor (MIF) gene knock-in mouse model reveals that protein interactions and not enzymatic activity mediate MIF-dependent growth regulation.

Authors:  Günter Fingerle-Rowson; Dayananda Rao Kaleswarapu; Corinna Schlander; Nazanin Kabgani; Tania Brocks; Nina Reinart; Raymonde Busch; Anke Schütz; Hongqi Lue; Xin Du; Aihua Liu; Huabao Xiong; Yibang Chen; Alice Nemajerova; Michael Hallek; Jürgen Bernhagen; Lin Leng; Richard Bucala
Journal:  Mol Cell Biol       Date:  2009-02-02       Impact factor: 4.272

8.  Modulation of expression and cellular distribution of p21 by macrophage migration inhibitory factor.

Authors:  Elliott Taranto; Jin R Xue; Eric F Morand; Michelle Leech
Journal:  J Inflamm (Lond)       Date:  2009-08-24       Impact factor: 4.981

9.  MIF homologues from a filarial nematode parasite synergize with IL-4 to induce alternative activation of host macrophages.

Authors:  Lidia Prieto-Lafuente; William F Gregory; Judith E Allen; Rick M Maizels
Journal:  J Leukoc Biol       Date:  2009-01-29       Impact factor: 4.962

10.  Restoration of contact inhibition in human glioblastoma cell lines after MIF knockdown.

Authors:  Jörg Schrader; Oliver Deuster; Birgit Rinn; Martina Schulz; Andreas Kautz; Richard Dodel; Bernhard Meyer; Yousef Al-Abed; Karthikeyan Balakrishnan; Jens P Reese; Michael Bacher
Journal:  BMC Cancer       Date:  2009-12-28       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.